A Multicenter Study To Evaluate The Safety And Efficacy Of Heber On (Interferon Alfa-2b) In Combination With Ribavirin For The Treatment Of Chronic Hepatitis C In Iran
Combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis C today. The aim of this study was to evaluate the efficacy and safety of thrice-weekly Heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis C. ...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Iran University of Medical Sciences
2005-05-01
|
Series: | Medical Journal of The Islamic Republic of Iran |
Subjects: | |
Online Access: | http://mjiri.tums.ac.ir/browse.php?a_code=A-10-1-253&slc_lang=en&sid=1 |